Navigation Links
TauRx Pharmaceuticals Receives $10.5m Follow-On Investment from Dundee Corporation
Date:3/4/2013

Dundee made its initial investment of USD20m in TauRx in September 2011.  Ned Goodman , President and Chief Executive Officer of Dundee, said: "TauRx has made good use of our initial investment, gaining regulatory clearance to initiate its Phase 3 study program for LMTX™ and establishing a network of experienced service providers to support the studies.  With the first patients now being enrolled into each of the three studies, and with the recent substantial strategic investment from the Genting Berhad group, this seems a highly opportune time to exercise the option we were granted by TauRx at the time of the initial investment and maintain Dundee's 5% interest in this commercially and scientifically promising company."

Professor Claude Wischik , Executive Chairman and Co-Founder of TauRx, said: "It is particularly gratifying to receive this follow-on investment from Dundee.  It made its initial investment at a time of critical importance to the development of both TauRx and our Tau aggregation inhibitor, LMTX™, and we see this additional investment of USD10.5m as a welcome vote of confidence in the commercial potential of our technology from a highly experienced investor.  We continue to believe strongly that Tau aggregation inhibition is the most promising approach to the long-term treatment of AD and other Tau-opathies such as bvFTD.  With expanding patient populations throughout the world due to an aging population, and with products based on beta-amyloid clearance still producing disappointing results in clinical studies, it is now critically important for healthcare systems, patients, their families and their careers to bring an effective treatment for these devastating diseases to market."

About TauRx Therapeutics:

TauRx Therapeutics Ltd was established in '/>"/>

SOURCE TauRx Pharmaceuticals Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Jazz Pharmaceuticals Announces Public Offering Of Ordinary Shares By Selling Shareholders
2. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
3. Auxilium Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Healthcare Conference
4. Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
5. AVANIR Pharmaceuticals To paticipate in two conferences in March
6. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013
7. Adamis Pharmaceuticals Prevails in License Dispute Litigation
8. Cumberland Pharmaceuticals Reports 2012 Annual Financial Results
9. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
10. Spring Bank Pharmaceuticals Closes $10.5 million Series A Financing to fund Phase I Clinical Trials in HCV-infected Patients
11. StockCall Insight into Eli Lilly, Bristol-Myers Squibb, Astex Pharmaceuticals and Raptor Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... LONDON , June 30, 2015 ... Street issued a survey to Rosacea sufferers as part of ... what treatments Rosacea sufferers found effective for their Rosacea. The ... age, and comprised 47% men and 53% women. ... of survey participants did not consider or attempt to visit ...
(Date:6/30/2015)... June 30, 2015 First Choice Wellness Care ... Astanza Duality and is the only clinic in the ... tattoo removal treatments. The practice has recently expanded their ... brand to showcase their focus in the procedure. They ... results, faster ink clearance, and superior service. ...
(Date:6/30/2015)... June 30, 2015  Avanir Pharmaceuticals, Inc. today ... showing that treatment with NUEDEXTA ® was ... of pseudobulbar affect (PBA) in patients with traumatic ... distressing condition characterized by sudden and uncontrollable outbursts ... diseases or brain injury. PRISM II is a ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7
(Date:6/30/2015)... ... June 30, 2015 , ... Broadway by the Sea posted ... patient and family member testimonials. Medicare rated the care center as a five-star location ... the video to give future patients a firsthand look at the facility’s satisfied residents. ...
(Date:6/30/2015)... ... 2015 , ... From the moment a patient enters the office of Dr. ... they receive and the luxury in which they are bathed. The office has ... offer the same experience, just better! , Their office is a state-of the-art facility ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... general manager of HRA Healthcare Research & Analytics , a consultative healthcare ... Associates, Inc. (MJH) family of businesses. HRA offers quantitative and qualitative, custom and ...
(Date:6/30/2015)... ... June 30, 2015 , ... Independence Day weekend is more than just fireworks ... kick off of July as National Hot Dog Month. Americans are expected to eat ... time of the year and enough to stretch from Washington D.C. to Los Angeles ...
(Date:6/30/2015)... Nashville, Tennessee (PRWEB) , ... ... ... provider of CorrectChemo®, the drug response profiling test to help oncologists provide ... GeneSourceTM. , “The CorrectChemo® assay provides the oncologist with valuable insight ...
Breaking Medicine News(10 mins):Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 3Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 4Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 3Health News:Biggest Hot Dog Weekend of the Year to Kick Off National Hot Dog Month 2Health News:Correct Chemo Joins NextGxDx Online Genetic Testing Marketplace 2Health News:Correct Chemo Joins NextGxDx Online Genetic Testing Marketplace 3
... Secretary of State for Research and Emilio Botn, ... Banco Santander Finantial City (located in Boadilla del ... imaging tests included in PESA (Progression of Early ... by National Center for Cardiovascular Research (CNIC) and ...
... Following the publication of several media reports which seriously ... by the Global Fund to Fight AIDS, TB and ... and governments to continue their funding. The Global ... attracts, manages and disburses resources to prevent and treat ...
... As mental health care costs and problem gambling rates ... a personalized feedback tool that could serve as an ... problems to get the help they need. Matthew ... in the MU College of Education, and his team ...
... physical exercise improve hormone levels and menstrual bleeding pattern ... from the University of Gothenburg, Sweden., PCOS is a ... women of child-bearing age. Women with PCOS frequently have ... follicles in the ovaries. This causes the ovaries to ...
... , MONDAY, Feb. 7 (HealthDay News) -- Heart attack ... and other procedures may have an increased risk of cancer, ... 82,861 patients who survived a heart attack between April 1996 ... one year of their heart attack, 77 percent of the ...
... , FRIDAY, Feb. 4 (HealthDay News) -- Middle-aged breast ... condition normally uncommon in women younger than 70, a new ... say that this may be because early menopause caused by ... could weaken the bones by the time women reach middle ...
Cached Medicine News:Health News:CNIC and Grupo Santander present a new venue for imaging tests included in PESA study 2Health News:CNIC and Grupo Santander present a new venue for imaging tests included in PESA study 3Health News:Media reports ignore that Global Fund resources deliver tremendous results in the fight against AIDS 2Health News:Simple feedback could be effective therapy for addictive behaviors 2Health News:Heart Scans May Raise Cancer Risk, Study Finds 2Health News:Breast Cancer Treatment May Lead to Hip Fracture 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: